Collagen molecular beacon for detecting subclinical surfactant skin damage
This innovative collagen-mimetic peptide (CMP) molecular beacon offers a sensitive method to detect subclinical collagen disruption from surfactant exposure on human skin. The beacon fluoresces upon binding damaged collagen, providing a simple, ratiometric detection method.
Overview
The collagen-mimetic peptide (CMP) molecular beacon represents a breakthrough in detecting subclinical skin damage caused by surfactants. This technology utilizes a synthetic peptide labeled with a fluorophore and quencher. Under normal conditions, the peptide remains compact, and its fluorescence is quenched. Upon binding to disrupted collagen strands, it extends, triggering a measurable fluorescence increase. This innovation allows for the detection of collagen damage at molecular levels, surpassing the sensitivity of traditional methods like TEWL or visual grading.
Technical specifications
- Fluorescence Activation: The beacon fluoresces upon binding to disrupted collagen, with a ratiometric output that eliminates the need for bound/unbound probe separation.
- Sensitivity: Capable of detecting collagen disruption at trace surfactant levels (<0.01 mg/cm²).
- Validation: Successfully tested on mammalian type I collagen with sequence-specific controls confirming its specificity.
- Sample Collection: Skin samples obtained via tape stripping serve as the substrate for testing.
Technology readiness level
Currently at TRL 4, the CMP molecular beacon has been validated in controlled laboratory settings. Future validation plans include optimizing the beacon's fluorescence properties, conducting ex vivo tests on human skin samples, and performing clinical pilot studies to confirm its practical applications and sensitivity enhancements over existing biophysical measurements.
About Massachusetts Institute of Technology
MIT is a private research university known for intensive, interdisciplinary discovery and a global scale of sponsored research. Industry engages through a long-standing corporate partnership program, on-campus collaboration spaces, and shared-use facilities that enable rapid prototyping and characterization. The institute also operates a federally funded R&D center and maintains close adjacency to Kendall Square, allowing company teams to embed with faculty and students and accelerate translation. Research is supported by competitive federal funding from NSF, NIH, DOE, and the Department of Defense. A dedicated technology transfer office, standardized agreements, and an affiliated deep-tech accelerator support IP, licensing, and startup formation.
Inquire about this partnering listing
Looking for
Industry applications
delivered to your inbox.